21 results
diagnosis medications table treatment cardiology inhibitors summary antiarrhythmics comparison differential dmii dpp4 renal sideeffects abscess acromegaly agonists algorithm anthracycline antidiabetic
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology ... #Pharmacology # ... Management
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... agent • Does not cause ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm Lifestyle Modifications (Diet and Exercise) -> Start
Diagnosis and Management ... relative with DM2 ... • Secondary Causes ... Screening #Targets #Management ... #DMII #Classification
Comparison of anti-diabetic or anti-hyperglycemic agents There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... #pharmacology #pharmacotherapy ... table #comparison #management ... #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide Classes ... #Mellitus #DM2 ... #Medications #pharmacology ... comparison #table #endocrinology
Oral Hypoglycemics in Diabetes Management 1 INSULIN SENSITIZER • TZD -
Hypoglycemics in Diabetes ... Management 1 ... Hypoglycemics #Diabetes ... #Management #pharmacology ... #DM2 #DMII #Classification
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
of anti-diabetic ... kidney), which causes ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... not definitively cause ... Receptor #Agonists #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Diabetic Ketoacidosis (DKA) - Pathogenesis and Clinical Findings • Note: in DKA, body K+ is lost
Diabetic Ketoacidosis ... anion gap until it closes ... DiabeticKetoacidosis #DKA #pathophysiology ... #endocrinology ... #diabetes
No results found for "pathophysiology pharmacology endocrinology causes classes classification management dm2 diabetes"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #pathophysiology #pharmacology #endocrinology #causes #classes #classification #management #dm2 #diabetes